A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects
Conditions: Pharmacology, Clinical; HealthyInterventions: Drug: Pomalidomide; Drug: Ketoconazole; Drug: Fluvoxamine; Drug: CarbamazepineSponsors: Celgene Corporation; Celgene CorporationCompleted - verified November 2012
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials